ERK5: A Novel IKKα-Kinase in Rat Hippocampal Neurons

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques

• Publication date

  2011-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1017/S0317167100012191PMID 21672705
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diabetes

  2013cited by this paper
• Insulin resistance and atherosclerosis.

  2012cited by this paper
• muscle cells

  2012cited by this paper
• Alzheimer's disease.

  2011cited by this paper
• Inflammation and NF-κB in Alzheimer's Disease and Diabetes

  2009cited by this paper
• Clusters of Hyperactive Neurons Near Amyloid Plaques in a Mouse Model of Alzheimer's Disease

  2008influential reference
• Tau phosphorylation by GSK-3β promotes tangle-like filament morphology

  2007influential reference
• Inhibition of Abeta production by NF-kappaB inhibitors.

  2007cited by this paper
• Regulation of ERK5 by insulin and angiotensin-II in vascular smooth muscle cells.

  2007cited by this paper
• Regulation of the G2–M cell cycle progression by the ERK5–NFκB signaling pathway

  2007cited by this paper
• Insulin resistance and atherosclerosis.

  2006cited by this paper
• 100 Years and Counting: Prospects for Defeating Alzheimer's Disease

  2006influential reference
• Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6

  2006cited by this paper
• Inhibition of A production by NF- B inhibitors

  2006cited by this paper
• Regulation and Function of IKK and IKK-Related Kinases

  2006cited by this paper
• Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: Relevance to Alzheimer's disease

  2005cited by this paper
• Increased risk of Alzheimer's disease in Type II diabetes: insulin resistance of the brain or insulin-induced amyloid pathology?

  2005cited by this paper
• Neuronal insulin signal transduction mechanisms in diabetes phenotypes.

  2005cited by this paper
• Dominant negative FTase (DNFTα) inhibits ERK5, MEF2C and CREB activation in adipogenesis

  2005cited by this paper
• Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease – is this type 3 diabetes?

  2005cited by this paper
• Influence of diabetes on the exacerbation of an inflammatory response in cardiovascular tissue.

  2004cited by this paper
• Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function.

  2004cited by this paper
• Role of extracellular signal regulated kinase 5 in neuronal survival.

  2004cited by this paper
• Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI

  2003cited by this paper
• Insulin Insults May Spur Alzheimer's Disease

  2003cited by this paper
• Neuroscience. Insulin insults may spur Alzheimer's disease.

  2003cited by this paper
• ERK5 activation of MEF2-mediated gene expression plays a critical role in BDNF-promoted survival of developing but not mature cortical neurons

  2003cited by this paper
• Diabetes Mellitus Is a Risk Factor for Vascular Dementia, but Not for Alzheimer's Disease: A Population-Based Study of the Oldest Old

  2002cited by this paper
• THE CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES

  2002cited by this paper
• ERK5 and ERK2 Cooperate to Regulate NF-κB and Cell Transformation*

  2001cited by this paper
• ERK5 and ERK2 cooperate to regulate NF-kappaB and cell transformation.

  2001cited by this paper
• Wortmannin inhibits pkb/akt phosphorylation and promotes gemcitabine antitumor activity in orthotopic human pancreatic cancer xenografts in immunodeficient mice.

  2001cited by this paper
• Extracellular signal regulated kinase 5 (ERK5) is required for the differentiation of muscle cells

  2001cited by this paper
• Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle.

  2000cited by this paper
• Potentiation of Rho-A-mediated Lysophosphatidic Acid Activity by Hyperinsulinemia*

  2000cited by this paper
• Insulin inhibits the expression of intercellular adhesion molecule-1 by human aortic endothelial cells through stimulation of nitric oxide.

  2000cited by this paper
• Hyperinsulinemia enhances transcriptional activity of nuclear factor-kappaB induced by angiotensin II, hyperglycemia, and advanced glycosylation end products in vascular smooth muscle cells.

  2000cited by this paper
• Contribution of the ERK5/MEK5 Pathway to Ras/Raf Signaling and Growth Control*

  1999cited by this paper
• Multiple signals converging on NF-kappaB.

  1999cited by this paper
• Multiple signals converging on NF-κB

  1999cited by this paper
• NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses.

  1998cited by this paper
• Insulin potentiates platelet-derived growth factor action in vascular smooth muscle cells.

  1998cited by this paper
• The 90-kDa ribosomal S6 kinase (pp90rsk) phosphorylates the N-terminal regulatory domain of IkappaBalpha and stimulates its degradation in vitro.

  1997cited by this paper
• Hyperinsulinemia potentiates activation of p21Ras by growth factors.

  1997cited by this paper
• NF-kappa B as a frequent target for immunosuppressive and anti-inflammatory molecules.

  1997cited by this paper
• NF-?B as a Frequent Target for Immunosuppressive and

  1997cited by this paper
• Advances in molecular and cellular endocrinology

  1997cited by this paper
• The 90-kDa Ribosomal S6 Kinase (pp90rsk) Phosphorylates the N-terminal Regulatory Domain of IκBα and Stimulates Its Degradation in Vitro *

  1997cited by this paper
• The NF-kappa B and I kappa B proteins: new discoveries and insights.

  1996cited by this paper
• NF-kappa B: ten years after.

  1996cited by this paper
• NF-κB: Ten Years After

  1996cited by this paper
• THE NF-κB AND IκB PROTEINS: New Discoveries and Insights

  1996cited by this paper
• Immunotoxins: an update.

  1996cited by this paper
• Site-specific phosphorylation of IkappaBalpha by a novel ubiquitination-dependent protein kinase activity.

  1996cited by this paper
• Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha.

  1994cited by this paper

• Discovery of the mechanism of n-propylparaben-promoting the proliferation of human breast adenocarcinoma cells by activating human estrogen receptors via metabolomics analysis

  2023cites this paper
• Transcriptome profiling and differential expression analysis of the immune-related genes during the early phase of acute infection with Aeromonas hydrophila in the Chinese sucker (Myxocyprinus asiaticus)

  2021cites this paper
• Biochanin A protects against PM2.5-induced acute pulmonary cell injury by interacting with the target protein MEK5.

  2019cites this paper
• Research Progresses of the Mechanism of Insulin Resistance in Type II Diabetes

  2019cites this paper
• Nous mecanismes implicats en els dèficits transcripcionals i la pèrdua del bdnf en la malaltia de huntington: descripció de noves dianes terapèutiques

  2018cites this paper
• Aberrant MEK5/ERK5 signalling contributes to human colon cancer progression via NF-κB activation

  2015cites this paper
• Differential expression of extracellular-signal-regulated kinase 5 (ERK5) in normal and degenerated human nucleus pulposus tissues and cells.

  2014cites this paper